FOUNDERS
Deepinder Goyal defends $30 million Temple wearable venture after stepping down from Eternal
The Eternal founder put $20 million of his own money into the head-worn wellness device ahead of its planned 2027 delivery.
Deepinder Goyal, founder of Eternal, has defended his decision to step down as chief executive of the $35 billion conglomerate to launch Temple, a high-end health and wellness wearable startup that has consumed $30 million in development funding so far.
Addressing public backlash and industry skepticism on X, Goyal stated he put $20 million of his own money into the venture, asserting that his motives are driven by research ambition rather than short-term financial returns.
Financial backing and cap table structure
Temple is opening pre-orders in India at Rs 85,000, with shipments scheduled for early 2027. According to Goyal, the startup’s capital structure includes internal backing alongside non-traditional financing channels.
The company raised a funding round from its own employees several months ago and is currently raising capital primarily from its customer base. Goyal argued that this cap table design refutes claims of the product being unproven, adding that the company offers a 14-day, no-questions-asked return policy.
The financial commitment includes a substantial personal stake from Goyal alongside early corporate expenditures:
| Parameter | Detail |
|---|---|
| Total R&D Expenditure | $30 million |
| Founder Personal Capital | $20 million |
| Retail Price | Rs 85,000 |
| Expected Shipping Date | Early 2027 |
| Eternal Group Valuation | $35 billion |
Goyal said that selling a few thousand units recovers only a fraction of the $30 million invested, contending that a scam would not operate under such economic terms or offer full refunds.
Technical features of Temple 01
Temple’s initial hardware iteration, Temple 01, is designed as a head-worn voice AI companion and wellness tracker. The device operates without a microphone, camera, or display screen.
Instead of traditional acoustic microphones, the wearable relies on integrated motion sensors to detect structural vibrations produced when the user speaks, converting those signals into text. Goyal described the architecture as room-deaf, meaning the device processes the wearer's vocal activity without recording ambient sound or surrounding conversations.
Users interact with the unit using a double-tap gesture, with haptic vibration feedback indicating when the system starts and stops listening. The hardware is designed to record notes, set reminders, draft messages, and log daily activities, including meals, exercise routines, and symptoms like headaches or dizziness.
On the physiological monitoring side, the company is developing functions for tracking heart rate, heart rate variability (HRV), sleep stages, REM sleep, VO2 max, continuous core body temperature, snoring patterns, sleep position, jaw clenching, and automatic chewing detection to estimate caloric intake.
Medical backlash and regulatory stance
The commercial rollout and pre-order phase have drawn sharp criticism from medical professionals, including Kerala-based hepatologist Dr Cyriac Abby Philips. Critics have challenged Temple’s claims regarding brain blood flow monitoring and biological entropy metrics, questioning whether sensors applied to the skin surface can provide accurate readings of cerebral hemodynamics.
In response, Goyal clarified that Temple is marketed exclusively as a fitness tracker and wellness device rather than a clinically certified medical device.
Goyal noted that most wearable technology platforms introduce products before peer-reviewed scientific literature is published. He cited Boston-based Whoop, which launched its performance band in 2015 years prior to published clinical validations. Goyal stated that pre-print research papers for Temple will precede full peer-reviewed studies, with independent external validation expected once units are in active consumer use.
Why it matters
For India's startup ecosystem, Goyal's transition from heading Eternal—a business built over 18 years to a $35 billion valuation—to building a hardware-heavy deep-tech product highlights a rare founder pivot in the domestic ecosystem.
The Rs 85,000 price point places Temple at the top tier of consumer electronics in India, testing local demand for high-margin hardware. Additionally, raising capital directly from customers and staff presents an alternative cap table strategy for early-stage hardware development, where capital intensity typically demands institutional venture capital.
Strategic outlook and future iterations
Goyal described Temple as an ongoing research and development platform rather than a static consumer product. The company plans to iterate through multiple product cycles, with Goyal outlining an ambition to develop up to 20 generations of the device.
While Temple 01 focuses on voice AI and physiological tracking, Goyal indicated that additional unannounced features remain under development, emphasizing that the team intends to establish validation progressively through public research outputs.